Please use this identifier to cite or link to this item:
Title: Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease
Authors: Boronat, Mauro 
García-Cantón, César 
López-Ríos, Laura
Quevedo, Virginia
Lorenzo, Dionisio L. 
Batista, Fátima
Riaño, Marta
Nóvoa, Francisco J.
UNESCO Clasification: 32 Ciencias médicas
3205 Medicina interna
Keywords: Apolipoprotein B100,
Low-density lipoprotein–cholesterol
Non-high-density lipoprotein–cholesterol
Cardiovascular risk
Lipid goals, et al
Issue Date: 2014
Journal: Diabetes and Vascular Disease Research 
Abstract: This study analyses discordance rates between attainment of therapeutic goals for apolipoprotein B100 (apoB) and both low-density lipoprotein-cholesterol (LDL-C) and non-high-density lipoprotein-cholesterol (non-HDL-C) in a sample of 152 patients with type 2 diabetes and chronic kidney disease from Gran Canaria (Spain), using treatment targets recommended by the American Diabetes Association/American College of Cardiology (ADA/ACC), the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) and by a Spanish population-based study. Among subjects with LDL-C levels at therapeutic goal, apoB was above target in 16.3% (ADA/ACC), 6.5% (ESC/EAS) and 39.1% (population-based criteria), and among subjects with non-HDL-C levels at therapeutic goal, apoB was above target in 10.5% (ADA/ACC), 1.2% (ESC/EAS) and 29.6% (population-based criteria). These findings show that clinical management would be very differently altered depending on the criteria used to set treatment targets for apoB. Cut-off points derived from population data identify a greater number of subjects suitable for a more intensive lipid-lowering therapy.
ISSN: 1479-1641
DOI: 10.1177/1479164113511834
Source: Diabetes and Vascular Disease Research [ISSN 1479-1641],v. 11, p. 53-59
Appears in Collections:Artículos
Show full item record

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.